SCHEMBL1901606

SCHEMBL1901606

CCC(C)Nc1ccccc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLCN2 P51788 2/20 0.53
KMT2A Q03164 5/20 0.51
MEN1 O00255 4/20 0.51
KDM4E B2RXH2 2/20 0.50
ABCC1 P33527 2/20 0.50
POLB P06746 1/20 0.50
HPGD P15428 2/20 0.49
ALDH1A1 P00352 1/20 0.49
HSD17B10 Q99714 1/20 0.49
RAB9A P51151 2/20 0.47
AGTR1 P30556 1/20 0.47
FABP4 P15090 1/20 0.47
MAPK8 P45983 1/20 0.47
CYP2C9 P11712 2/20 0.47
AKR1B10 O60218 1/20 0.46
TRPA1 O75762 1/20 0.46
ABCB11 O95342 1/20 0.46
DHFR P00374 1/20 0.46
LMNA P02545 1/20 0.46
MPO P05164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28874209 0.88 KMT2A (0.49) CLCN2KMT2AMEN1KDM4EABCC1
SCHEMBL12964105 0.88 MEN1 (0.50) CLCN2KMT2AMEN1ALDH1A1HSD17B10
SCHEMBL10613997 0.86 MEN1 (0.49) KMT2AMEN1KDM4EHPGDALDH1A1
SCHEMBL2783481 0.84 CLCN2 (0.51) CLCN2KMT2AMEN1KDM4EABCC1
SCHEMBL1899962 0.83 KMT2A (0.54) CLCN2KMT2AMEN1KDM4EHPGD
SCHEMBL5515000 0.83 CLCN2 (0.50) CLCN2KMT2AMEN1KDM4EABCC1
SCHEMBL23144741 0.82 KDM4E (0.59) KMT2AKDM4EHPGDALDH1A1HSD17B10
SCHEMBL8520231 0.82 POLB (0.55) KMT2AMEN1KDM4EABCC1POLB
SCHEMBL19750094 0.81 KMT2A (0.53) CLCN2KMT2AMEN1KDM4EHPGD
SCHEMBL4897621 0.81 KDM4E (0.57) CLCN2KMT2AMEN1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365596-B2 Method for preparing quaternary phosphonium salts MICROVAST POWER SYSTEMS CO., LTD. (CN) 2016-06-14 US claimed
US-20150166587-A1 METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS MICROVAST POWER SYSTEMS CO., LTD. (CN) 2015-06-18 US claimed
EP-3416176-B1 ELECTROLYTE SOLUTION FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR UTILIZING SAID ELECTROLYTE SOLUTION SANYO CHEMICAL IND LTD (JP) 2026-01-07 EP disclosed
WO-2024090362-A1 CHARGE-TRANSPORTING COMPOSITION 日産化学株式会社 2024-05-02 WO disclosed
WO-2023081759-A1 BIFUNCTIONAL PI3K-ALPHA INHIBITORS AND USES THEREOF RELAY THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed
EP-3480835-B1 ELECTROLYTIC SOLUTION FOR ELECTROLYTIC CAPACITOR, AND ELECTROLYTIC CAPACITOR SANYO CHEMICAL IND LTD (JP) 2022-12-21 EP disclosed
US-11527365-B2 Electrolytic solution for electrolytic capacitor, and electrolytic capacitor SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2022-12-13 US disclosed
US-11309136-B2 Electrolyte solution for electrolytic capacitor and electrolytic capacitor utilizing said electrolyte solution SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2022-04-19 US disclosed
CN-109313987-B Electrolytic solution for electrolytic capacitor and electrolytic capacitor 三洋化成工业株式会社 2021-06-29 CN disclosed
US-20210193394-A1 ELECTROLYTE SOLUTION FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR UTILIZING SAID ELECTROLYTE SOLUTION SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2021-06-24 US disclosed
EP-2634204-B1 CONDUCTIVE ANILINE POLYMER, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CONDUCTIVE FILM MITSUBISHI CHEM CORP (JP) 2021-03-31 EP disclosed
WO-1993008176-A1 BENZODIAZEPINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF CHOLECYSTOKININ AND/OR GASTRIN RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 1993-04-29 WO disclosed
EP-0539170-A1 Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors MERCK SHARP & DOHME LTD. (GB) 1993-04-28 EP disclosed
EP-0291074-B1 PROCESS FOR PRODUCING QUATERNARY SALTS MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1992-01-29 EP disclosed
EP-0246825-B1 QUATERNARY SALT SOLUTION ELECTROLYTE FOR ELECTROLYTIC CAPACITORS MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1991-02-27 EP disclosed
US-4892944-A Process for producing quaternary salts MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1990-01-09 US disclosed
EP-0291074-A2 Process for producing quaternary salts MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1988-11-17 EP disclosed
US-4774011-A Electrolyte for aluminum electrolytic capacitor MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1988-09-27 US disclosed
US-4715976-A QUATERNARY AMMONIUM SALT OF CARBOXYLIC ACID IN APROTIC SOLVENT MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1987-12-29 US disclosed
EP-0227433-A2 Electrolyte solution of quaternary ammonium salt for electrolytic capacitor MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1987-07-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166587-A1 METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS PHPT1, PHOSPHO1, PTEN CLCN2 1561/4885KMT2A 2330/4885MEN1 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.